impact anticip
though lower estim coven appear
safe breach
yesterday even lower guidanc cite materi
deterior global trial activ revis revenu guidanc impli
reduct midpoint revenu impact
unsurprisingli come segment saw exit
global site temporarili inaccess expect trial activ
remain pressur near term lower estim
week back link cut may aggress enough
said remain buy market appear price
news lower guidanc cite materi deterior
global trial activ revis guidanc tabl impli
reduct midpoint revenu impact rang
ta segment csm segment expect
unchang prior guidanc march busi experienc
averag global site closur exit first quarter substanti
lower global site temporarili inaccess suggest last
sever week march recogn notabl deceler trial activ
estim come extrapol lower guidanc
believ entir driven month march estim
full quarter impact would take midpoint
quarterli revenu prior model haircut
accordingli lower estim
captur extrapol guidanc full quarterli impact
ebitda came prior estim
full year model neg growth
ep estim lower impli better ramp
 mil
mil
tr target
busi model revenu ep
implic debt coven recent publish note link assess balanc sheet
strength abil withstand associ debt coven believ key annual
estim believ impact quarter annual estim
ebitda get still well trigger ebitda recogn
possibl implic cover
revis estim impli sequenti mid-teen declin revenu current model
reflect declin clinic solut busi
iclr assum similar level magnitud think current estim iclr
could risk
pt pt impli multipl ep estim
page
page
sandi draper statement dollar y/i total gross depreci restructur merger related- impair oper fit incl restruc net interest expens incom incom incom tax tax equiti unconsolid equiti earn unconsolid net net loss incom attribut non-controlling net incom attribut dilut dilut share forma adjust net adj pre-tax tax non-gaap net non-gaap growth forma adjust ebitdaadjust margin robinson humphrey research estimatestick iqva
iqvia largest cro revenu oper countri employe
compani found headquart durham nc compani formerli quintil
merg im health combin entiti iqvia oper three segment commerci
solut data technolog drive real world evid use life scienc client clinic
trial integr healthcar servic contract sale compris
respect sale iqvia first went public taken privat privat equiti
went public
buy rate base view ebitda growth exceed revenu growth due
oper leverag cost synergi recognit expect manag reinforc oper
perform share repurchas expect contribut mid-teen ep growth
valuat risk
pt assign probabl low case price-to-earnings stock mid case
high case pt impli price-to-earnings multipl
ep estim low end two year averag ntm price-to-earnings given expect
materi headwind revenu earn
risk rate price target
unexpect cancel late stage busi net book bill trend deterior
leverag start increas
sandi draper herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
